COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1627: Articles 16261-16270  | Next

SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity
Nunez, I. A., Lien, C. Z., Selvaraj, P., Stauft, C. B., Liu, S., Starost, M., Wang, T.
10.1101/2021.04.02.438186 — Posted: 2021-04-02
A high-throughput fluorescence polarization assay to discover inhibitors of arenavirus and coronavirus exoribonucleases
Hernandez Tapia, S. G., Feracci, M., De Jesus, C. T., El-Kazzi, P., Kaci, R., Garlatti, L., Decroly, E., Canard, B., Ferron, F., Alvarez, K.
10.1101/2021.04.02.437736 — Posted: 2021-04-02
One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization
Gu, M., Torres, J. L., Greenhouse, J., Wallace, S., Chiang, C.-I., Jackson, A. M., Porto, M., Kar, S., Li, Y., Ward, A. B., Wang, Y.
10.1101/2021.04.02.438218 — Posted: 2021-04-02
A realistic touch-transfer method reveals low risk of transmission for SARS-CoV-2 by contaminated coins and bank notes
Todt, D., Meister, T. L., Tamele, B., Howes, J., Paulmann, D., Becker, B., Brill, F. H., Wind, M., Schijven, J., Mhlekude, B., Goffinet, C., Krawczyk, A., Steinmann, J., Pfaender, S., Brueggemann, Y., Steinmann, E.
10.1101/2021.04.02.438182 — Posted: 2021-04-02
Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants
Ikegame, S., Siddiquey, M. N. A., Hung, C.-T., Haas, G., Brambilla, L., Oguntuyo, K. Y., Kowdle, S., Vilardo, A. E., Edelstein, A., Perandones, C., Kamil, J. P., Lee, B.
10.1101/2021.03.31.21254660 — Posted: 2021-04-02 Discussion: Offsite
Fine-tuning the Spike: Role of the nature and topology of the glycan shield structure and dynamics of SARS-CoV-2 S
Harbison, A. M., Fogarty, C. A., Phung, T. K., Satheesan, A., Schulz, B. L., Fadda, E.
10.1101/2021.04.01.438036 — Posted: 2021-04-01
Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein
Zhang, S., Go, E. P., Ding, H., Anang, S., Kappes, J. C., Desaire, H., Sodroski, J. G.
10.1101/2021.04.01.438120 — Posted: 2021-04-01
Placental expression of ACE2 and TMPRSS2 in maternal SARS-CoV-2 infection: are placental defenses mediated by fetal sex?
Shook, L. L., Bordt, E. A., Meinsohn, M.-C., Pepin, D., De Guzman, R. M., Brigada, S., Yockey, L. J., James, K. E., Sullivan, M. W., Bebell, L. M., Roberts, D. J., Kaimal, A. J., Li, J. Z., Schust, D., Gray, K. J., Edlow, A. G.
10.1101/2021.04.01.438089 — Posted: 2021-04-01
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites
Hoffmann, D., Mereiter, S., Oh, Y. J., Monteil, V., Zhu, R., Canena, D., Hain, L., Laurent, E., Gruber, C., Novatchkova, M., Ticevic, M., Chabloz, A., Wirnsberger, G., Hagelkrueys, A., Altmann, F., Mach, L., Stadlmann, J., Oostenbrink, C., Mirazimi, A., Hinterdorfer, P., Penninger, J. M.
10.1101/2021.04.01.438087 — Posted: 2021-04-01
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Cho, H., Gonzales-Wartz, K. K., Huang, D., Yuan, M., Peterson, M., Liang, J., Beutler, N., Torres, J. L., Cong, Y., Postnikova, E., Bangaru, S., Talana, C. A., Shi, W., Yang, E. S., Zhang, Y., Leung, K., Wang, L., Peng, L., Skinner, J., Li, S., Wu, N. C., Liu, H., Dacon, C., Moyer, T., Cohen, M., Zhao, M., Lee, F. E.-H., Weinberg, R. S., Douagi, I., Gross, R., Schmaljohn, C., Pegu, A., Mascola, J. R., Holbrook, M., Nemazee, D., Rogers, T. F., Ward, A. B., Wilson, I. A., Crompton, P. D., Tan, J.
10.1101/2021.04.01.437942 — Posted: 2021-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).